Renaissance Technologies (RenTech)'s RIGL Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 338,441 shares of Rigel Pharmaceuticals, Inc. (RIGL) worth $9.15 M, representing 0.01% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 8 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in RIGL for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 237,763 shares. Largest reduction occurred in Q1 2026, reducing 200,568 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Rigel Pharmaceuticals (RIGL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Rigel Pharmaceuticals (RIGL) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -200,568 | Reduce 37.21% | 338,441 | $27.04 |
| Q4 2025 | +64,800 | Add 13.66% | 539,009 | $42.83 |
| Q3 2025 | +237,763 | Add 100.56% | 474,209 | $28.33 |
| Q2 2025 | +35,300 | Add 17.55% | 236,446 | $18.73 |
| Q1 2025 | -98,563 | Reduce 32.89% | 201,146 | $17.99 |
| Q4 2024 | +157,763 | Add 111.14% | 299,709 | $16.82 |
| Q3 2024 | -3,000 | Reduce 2.07% | 141,946 | $16.18 |
| Q2 2024 | +144,946 | New Buy | 144,946 | $8.22 |
Renaissance Technologies (RenTech)'s Rigel Pharmaceuticals Investment FAQs
Renaissance Technologies (RenTech) first purchased Rigel Pharmaceuticals, Inc. (RIGL) in Q2 2024, acquiring 144,946 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Rigel Pharmaceuticals, Inc. (RIGL) for 8 quarters since Q2 2024.
Renaissance Technologies (RenTech)'s largest addition to Rigel Pharmaceuticals, Inc. (RIGL) was in Q3 2025, adding 474,209 shares worth $13.43 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 338,441 shares of Rigel Pharmaceuticals, Inc. (RIGL), valued at approximately $9.15 M.
As of the Q1 2026 filing, Rigel Pharmaceuticals, Inc. (RIGL) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Rigel Pharmaceuticals, Inc. (RIGL) was 539,009 shares, as reported at the end of Q4 2025.